HealthEquity, Inc. (HQY) on Decifer

Decifer ranks HQY number 127 of 277 tracked names on durable business quality.

Why it ranks here

• Its returns on invested money are modest, around 8% and those returns have been improving and it turns most of its profit into real cash.
• Revenue is growing about 9% a year and profits grew 125% over the past year.
• It keeps a high share of every sale as profit, with profitability widening as it grows.
• and has the balance sheet to fund its growth.
• And it returns cash to shareholders.
• Profits up 125% and momentum of 17 out of 35 help, but modest returns around 8% and no worldview role hold it in the middle.

The current read

The evidence on HQY lines up on the supportive side: the intelligence feed flags this name as connected to what is moving markets now. The independent signals we track are telling the same story.

Themes

• Healthcare, Biotech & Devices: HealthEquity, Inc. operates in medical - healthcare information services. That places it inside the Healthcare, Biotech & Devices story.

Read the full HQY research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.